Physician profile
Alfredo Alejandro Santillan Gomez
NPI 1124213400
$125,019.91
in general payments reported to CMS, 2019-2025
27 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $139 · 2021: $7,618 · 2022: $2,154 · 2023: $54K · 2024: $47K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $92K · Consulting Fee: $16K · Food and Beverage: $4,681 · Travel and Lodging: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $92,125.00 |
| Consulting Fee | $16,465.00 |
| Food and Beverage | $4,681.47 |
| Travel and Lodging | $1,400.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $105,126.59 | 2020-2025 | Myrisk, Precisetumor, Genesight |
| Merit Medical Systems INC | $17,256.39 | 2023-2025 | Savi Scout |
| Baxter Healthcare | $497.03 | 2024-2025 | Tisseel, Perclot |
| Abbvie INC. | $470.12 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $268.16 | 2021-2025 | Airsupra, Lynparza |
| Endomagnetics Ltd | $159.71 | 2024 | Magseed, Magtrace |
| Nevro Corp. | $149.92 | 2023 | Senza |
| Amgen INC. | $139.88 | 2019-2025 | Evenity |
| Lilly USA, LLC | $134.50 | 2020-2022 | |
| Ethicon US, LLC | $121.04 | 2025 | Harmonic, Enseal, Echelon Flex |
| Genentech USA, INC. | $118.75 | 2019 | |
| Pulse Biosciences, INC. | $91.91 | 2025 | Cellfx |
| Janssen Pharmaceuticals, INC | $90.27 | 2023 | Spravato |
| Novartis Pharmaceuticals Corporation | $87.88 | 2019-2020 | |
| Kci USA, INC. | $45.74 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $36.05 | 2023-2024 | |
| Caris Mpi, INC. | $34.91 | 2025 | Mi Cancer Seek |
| Tactile Systems Technology INC | $33.33 | 2025 | Nimbl, Flexitouch Plus |
| Molli Surgical (US) INC | $28.94 | 2024 | |
| Seagen INC. | $26.41 | 2019 | |
| Genzyme Corporation | $23.19 | 2019 | |
| Janssen Biotech, INC. | $15.82 | 2025 | Erleada |
| E.R. Squibb & Sons, L.L.C. | $14.57 | 2019 | |
| Pfizer INC. | $13.04 | 2021 | |
| Merck Sharp & Dohme LLC | $12.47 | 2019 | |
| Trevena, INC. | $12.41 | 2021 | |
| Intuitive Surgical, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Santillan Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.